Tag: Gamma-secretase inhibitor therapy

Home / Gamma-secretase inhibitor therapy

Categories

Nirogacestat is approved by the USFDA for desmoid tumors

The Food and Drug Administration authorized nirogacestat (OGSIVEO, SpringWorks Therapeutics, Inc.) on November 27, 2023, for adult patients with advancing desmoid tumors needing systemic treatment. T...
gamma-secretase-inhibitor-therapy

Scan the code